Replies to post #155531 on Anavex Life Sciences Corp (AVXL)

[dia76ca]

Looking at the Anavex May 2018 presentation I note that they say they have in development 3-71 and 1-41 both targeting Alzheimer's! It would be interesting to know if these are designed to complement the lead drug!

See slide 6 at http://www.anavex.com/wp-content/uploads/2018/05/Anavex-Presentation-May-2018-1.pdf